Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Central Nervous System - Alzheimer Disease Drug Pipeline Report' returned 125 results - Page 1 of 7   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Central Nervous System - Parkinson Disease Drug Pipeline Report   Life Science Analytics, June 2007, Pages: 18 Life Science Analytics, "Central Nervous System - Parkinson Disease Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology   GBI Research, May 2011, Pages: 119 .4.1 Introduction 36 4.4.2 Pipeline Analysis 36 4.5 Central Nervous System 39 4.5.1 Introduction 39 4.5.2 Pipeline Analysis 40 4.6 Cardiovascular Diseases 44 4.6.1 Introduction 44 4.6.2 Pipeline Analysis 44 4 Oral Drug Delivery Market - Controlled and Sustained Release to be Major Revenue Generators   GBI Research, Nov 2010, Pages: 85 Systems 9.5 Central Nervous System 9.5.1 Analysis of the Global Migraine Therapeutics Market and Applications of Oral Drug Delivery Systems 9.5.2 Analysis of the Global Parkinson’s Disease Therapeutics Stroke_Central Nervous System Therapy Area Pipeline Report   Life Science Analytics, March 2009, Pages: 123 Life Science Analytics, Stroke_Central Nervous System Therapy Area Pipeline Report contains detailed information on the stroke - central nervous system drug pipeline. This report provides insight Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development   GBI Research, July 2011, Pages: 132 disorders and central nervous system disorders. Oncology accounts for the majority of pipeline activity, with 37% of the entire pipeline. The focus on oncology to develop novel anti-cancer drugs is driven Acute Lymphocytic Leukemia - Unmet Needs in Adult and Pediatric Populations Drive Recent Market Developments   Decision Resources, Inc., June 2010, Pages: 44 ) and Sprycel (Dasatinib) -- Central Nervous System Prophylaxis - Drug Resistance - Stem Cell Transplantation -- Myeloablative Regimens -- Allogeneic Stem Cell Transplantation -- Autologous Stem Cell Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions   GBI Research, Dec 2010, Pages: 177 For CNS Therapeutics Market 4.5.2 Restraints For CNS Therapeutics Market 4.5.3 Merger And Acquisition Deals Landscape For Central Nervous System (CNS) Therapeutics, 2009-2010 4.6 Autoimmune Disease Pain Therapeutics - Drugs, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 532 in the central nervous system Opioid receptors Role of AMPA receptors in chronic pain Kinins Serotonin Substance P Excitatory amino acids Role of nitric oxide in pain Prostaglandins Endocannabinoids Central Nervous System Attention Deficit Disorder with Hyperactivity   Life Science Analytics, March 2008, Pages: 99 "Central Nervous System Attention Deficit Disorder with Hyperactivity " contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy Opportunities in Orphan Drugs: Strategies for developing maximum returns from niche indications   Business Insights, Jan 2010, Pages: 106 opportunities to gain access to further orphan indications which have a similar disease mechanism. Key findings from this report - The developers of orphan drugs receive several incentives from the governments Central Nervous System Insomnia or Sleep Disorders   Life Science Analytics, March 2008, Pages: 172 "Central Nervous System Insomnia or Sleep Disorders " contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company Central Nervous System Seizures   Life Science Analytics, March 2008, Pages: 81 "Central Nervous System Seizures " contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing   GBI Research, Nov 2011, Pages: 143 by Therapeutic Class 42 6.1 Central Nervous System 46 6.1.1 Introduction 46 6.1.2 Pipeline Profile 46 6.1.3 Major Indications 47 6.2 Oncology 52 6.2.1 Introduction 52 6.2.2 Pipeline Profile 52 6.2.3 Major Central Nervous System Psychotic Disorders   Life Science Analytics, March 2008, Pages: 87 "Central Nervous System Psychotic Disorders " contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company Emerging Technologies: Stem Cells   Datamonitor, Nov 2011, Pages: 61 Weaknesses Threats STEM CELL PIPELINE Key findings Stem cell pipeline overview Cardiovascular Central nervous system Ophthalmology Endocrine and metabolic disorders Immunology Pediatric Drugs and Vaccines - Global Strategic Business Report   Global Industry Analysts, Inc., April 2011, Pages: 1088 26 Treatment 27 Osteogenic Sarcoma 27 Prevalence 27 Symptoms and Treatment 27 Central Nervous System Disorders 28 Mental Disorders 28 Prevalence 28 Attention Deficit Hyperactivity Disorder 29 Big Pharma's Key Lifecycle Management Strategies - Maximizing the Market Potential   GBI Research, Feb 2010, Pages: 85 in terms of the LCM pipeline. - Insight into the LCM activities in the top five therapeutic areas including cancer, central nervous system (CNS), cardiovascular system (CVS), metabolic diseases The Pharma R&D Fact Book 2007   Espicom Business Intelligence Ltd, Nov 2007, Pages: 614 HAEMATOLOGY IMMUNOLOGY INFLAMMATION ONCOLOGY OTHER Astelas Pharma R&D PIPELINE CARDIOVASCULAR UROLOGY INFLAMMATION & IMMUNOLOGY GASTROINTESTINAL INFECTIOUS DISEASE CENTRAL NERVOUS SYSTEM. METABOLIC BONE Central Nervous System - Pain Drug Pipeline Report   Life Science Analytics, June 2007, Pages: 27 Life Science Analytics, "Central Nervous System - Pain Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of pain Central Nervous System - Schizophrenia Drug Pipeline Report   Life Science Analytics, June 2007, Pages: 20 Life Science Analytics, "Central Nervous System - Schizophrenia Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network